News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
Wuxi Series Rebound; WUXI XDC (02268.HK) Resurges 7.5%
The stock price of the Wuxi series has rebounded today (6 Dec). After dropping for 2 days in a row from its listing high, WUXI XDC (02268.HK), which has been listed for less than a...
Reset
Send
The window will close in 5 seconds
Wuxi Series Rebound; WUXI XDC (02268.HK) Resurges 7.5%
Close
Recommend
12
Positive
14
Negative
9
 
SHORT SELL
 
STOCK INFO

The stock price of the Wuxi series has rebounded today (6 Dec). After dropping for 2 days in a row from its listing high, WUXI XDC (02268.HK)  +0.350 (+0.951%)    Short selling $21.59M; Ratio 12.510%   , which has been listed for less than a month, resumed its uptrend today, reaching a high of $30.4. It now trades at $29.5, up 7.5%.

Pharmaceutical stock JW THERAP-B (02126.HK)  -0.040 (-2.484%)   crossed the 10MA ($3) and peaked at $3.32. It is now standing at $3.18, elevating 6.7%.

Related NewsCICC Lists Situation of CN Active Stock-oriented Funds' Heavyweight HK Stocks in 1Q (Table)
Blue-chip newcomer WUXI APPTEC (02359.HK)  -0.650 (-1.122%)    Short selling $51.01M; Ratio 8.490%   reached as high as $84.1. It trades at $82.5, elevating 1.9%.

Blue-chip WUXI BIO (02269.HK)  -0.050 (-0.219%)    Short selling $201.21M; Ratio 24.921%   , which plans to buy back up to $600 million in shares, stopped its 2-day falling streak, and rebounded from a low of over 3.5 years to as high as $32.15. It now anchors at $30.7, rising 1.2%.

(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-04-25 16:25.)

Related NewsM Stanley's Latest List of Overweight-rated Stocks in APAC w/ Top-ranked MOST Score (Table)

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.